Product Code: RP-ID-10013264 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Healthcare & Pharmaceuticals |
Report ID: 10013264
Market Overview:
Global Sepsis Diagnostics Market Size Study, by Technology (Microbiology, Molecular Diagnostics, Immunoassay, Flow Cytometry, Microfluidics, Biomakers) by Product (Instruments, Blood-Culture Media, Assays & Reagents, Software) by Method (Conventional Diagnostics, Automated Diagnostics) by Test-Type (Laboratory, Point-of-Care) by End-Use (Hospital, Pathology & Reference Laboratories) by Regional Forecasts 2017-2025
Global Sepsis Diagnostics Market valued approximately USD 340 million in 2016 is anticipated to grow with a healthy growth rate of more than 9% over the forecast period 2017-2025. Sepsis means reaction of the body to the bacterial, viral, fungal, or parasitic infection, that may further lead to inflammatory reaction and organ failure or organ dysfunction. It affects several people in different manner as per their severity of infection, race, ethnicity, age etc. It is more common in the elderly and infants’. Major drivers such as increasing prevalence of sepsis across the world, growing geriatric population, increasing government initiatives for sepsis awareness, and increasing incidence of hospital-acquired infections are likely to give growth to the sepsis diagnosis market.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Technology:
 Microbiology
 Molecular Diagnostics
o Polymerase Chain Reaction
o Peptide Nucleic Acid-Fluorescent in Situ Hybridization
o Syndromic Panel-Based Testing
 Immunoassay
 Flow Cytometry
 Microfluidics
 Biomarkers
By Product:
 Instruments
 Blood-Culture Media
 Assays & Reagents
 Software
By Method:
 Conventional Diagnostics
 Automated Diagnostics
By Test Type:
 Laboratory
 Point-Of-Care Tests
By End-Use:
 Hospitals
 Pathology & Reference Laboratories
By Regions:
 North America
o U.S.
o Canada
 Europe
o UK
o Germany
 Asia Pacific
o China
o India
o Japan
 Latin America
o Brazil
o Mexico
 Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2015
Base year – 2016
Forecast period – 2017 to 2025
Some of the key manufacturers involved in the market Biomerieux, T2 Biosystems, Luminex
Becton, Dickinson, & Company (BD), Roche Diagnostics, Danaher, Thermo Fisher Scientific, Bruker, Abbott, Axis-Shield Diagnostics, Cytosorbents, Mitsubishi Chemical Europe, EKF Diagnostics, Immunexpress Frequent cross industry partnerships are leading to market consolidation.
Target Audience of the Global Sepsis Diagnostics Market in Market Study:
 Key Consulting Companies & Advisors
 Large, medium-sized, and small enterprises
 Venture capitalists
 Value-Added Resellers (VARs)
 Third-party knowledge providers
 Investment bankers
 Investors
Luminex
Becton, Dickinson, & Company (BD)
Roche Diagnostics
Danaher
Thermo Fisher Scientific
Bruker
Abbott
Axis-Shield Diagnostics
Cytosorbents
Mitsubishi Chemical Europe
EKF Diagnostics
Immunexpress
Related Reports
Proof of Quality & Reliability
